Literature DB >> 2167246

Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts.

A Ito1, T Sato, T Iga, Y Mori.   

Abstract

The production of tissue inhibitor of metalloproteinases (TIMP) in human uterine cervical fibroblasts was increased by human recombinant tumor necrosis factor alpha (hrTNF) at a low concentration (0.005 ng/ml) but the elevated synthesis was suppressed in a dose-dependent manner at higher concentrations (up to 50 ng/ml). In contrast, the production of collagenase (EC 3.4.24.7) and stromelysin was stimulated at all the corresponding concentrations. In contrast, human recombinant interleukin-1 alpha (hr IL-1, 10 ng/ml) coordinately induced these enzymes and TIMP production. The reduction of the elevated TIMP production by TNF was not due to the inhibition of TIMP secretion. These results suggest that TNF modulates the extracellular matrix degradation in human fibroblasts bifunctionally by the suppression of TIMP production in addition to the acceleration of matrix metalloproteinases production. Furthermore, the fact that TNF and IL-1 differently controlled the production of TIMP suggests that the signal pathway of TNF for TIMP production is different from that of IL-1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167246     DOI: 10.1016/0014-5793(90)81127-a

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Topical application of recombinant platelet-derived growth factor increases the rate of healing and the level of proteins that regulate this response.

Authors:  Santosh Gowda; David A Weinstein; Timothy D Blalock; Kavita Gandhi; Bruce A Mast; Gloria Chin; Gregory S Schultz
Journal:  Int Wound J       Date:  2013-10-07       Impact factor: 3.315

2.  Changes in serum levels of metalloproteinases and their inhibitors by treatment of chronic hepatitis C with interferon.

Authors:  M Arai; M Niioka; K Maruyama; N Wada; N Fujimoto; T Nomiyama; S Tanaka; I Okazaki
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

3.  Keratinocytes modulate the biosynthetic phenotype of dermal fibroblasts at a pretranslational level in a human skin equivalent.

Authors:  M Lacroix; T Bovy; B V Nusgens; C M Lapière
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

4.  Topical application of the tumour necrosis factor-alpha antibody infliximab improves healing of chronic wounds.

Authors:  Markus Streit; Zsuzsanna Beleznay; Lasse R Braathen
Journal:  Int Wound J       Date:  2006-09       Impact factor: 3.315

5.  Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.

Authors:  A Pagenstecher; A K Stalder; C L Kincaid; S D Shapiro; I L Campbell
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

6.  Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.

Authors:  B von Lampe; B Barthel; S E Coupland; E O Riecken; S Rosewicz
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

7.  Modulation of proteases and their inhibitors in immortal human osteoblast-like cells by tumor necrosis factor-alpha in vitro.

Authors:  F S Panagakos; S Kumar
Journal:  Inflammation       Date:  1994-06       Impact factor: 4.092

8.  Age-dependent increases in interstitial collagenase and MAP Kinase levels are exacerbated by superoxide dismutase deficiencies.

Authors:  Jaya Dasgupta; Supriya Kar; Holly Van Remmen; J Andres Melendez
Journal:  Exp Gerontol       Date:  2009-05-03       Impact factor: 4.032

9.  Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.

Authors:  M S Naylor; G W Stamp; W D Foulkes; D Eccles; F R Balkwill
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 10.  Tumor invasion, proteolysis, and angiogenesis.

Authors:  U P Thorgeirsson; C K Lindsay; D W Cottam; D E Gomez
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.